2
Participants
Start Date
April 7, 2021
Primary Completion Date
February 18, 2022
Study Completion Date
February 18, 2022
JNJ-40346527
Active study drug
Placebo
Non-active study drug
Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge
South London and Maudsley Hospital NHS Foundation Trust, London
Oxford Health NHS Trust, Oxford
Collaborators (1)
Janssen Pharmaceutica
INDUSTRY
University of Oxford
OTHER